Therefore, we hypothesized that tRF-17-79MP9PP-mediated THBS1 inhibition may lead to the inactivation of TGF-β1/Smad3 signaling pathway in breast cancer cells (Figure 7C). Here, SMAD3 is linked to breast carcinoma.